TrialNeuro-oncology2015

Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma.

David A Reardon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.